RT Book, Section A1 Gengo, Francis M. A1 Rainka, Michelle M. A2 Bertino, Joseph S. A2 DeVane, C. Lindsay A2 Fuhr, Uwe A2 Kashuba, Angela D. A2 Ma, Joseph D. SR Print(0) ID 56877720 T1 Chapter 16. Pharmacogenomics in Neurology T2 Pharmacogenomics: An Introduction and Clinical Perspective YR 2013 FD 2013 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-174169-9 LK accesspharmacy.mhmedical.com/content.aspx?aid=56877720 RD 2024/03/28 AB Review specific neurological disease states and the pharmacogenomics of these.Discuss how pharmacogenomics affects response to drug therapy and its implications.Outline how pharmacogenomics and pharmacogenomic testing will have an impact on diagnosis and treatment of neurological disease states.